stockrowMedline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) Free cash flow margin
Medline Inc.'s free cash flow margin over the twelve months to 30 September 2026 was 10.1%, up 5.6 percentage points from fiscal 2025 (4.56%). That is above the Medical Instruments & Supplies industry median of 2.36% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 4.56% | (0.99) |
| FY2024 | 5.55% | (0.52) |
| FY2023 | 6.07% | — |
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | 31.5% |
| RMD ResMed Inc. compare | 27.7% |
| COO The Cooper Companies, Inc. compare | 16.0% |
| BDX Becton, Dickinson and Company compare | 15.4% |
| ALC Alcon compare | 14.7% |
| WST West Pharmaceutical Services, Inc. compare | 13.4% |
| MDLN Medline Inc. | 10.1% |
| BAX Baxter International Inc. compare | 9.79% |
| SOLV Solventum Corporation compare | 0.00% |
| Medical Instruments & Supplies industry median | 2.36% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue